SCHEMBL23709331

SCHEMBL23709331

CCn1nc(C)cc1C(=O)Nc1nc2c(C)cccc2n1C/C=C/Cn1c(NC(O)c2cc(C)nn2CC)nc2cc(C(N)=O)ccc21

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 20/20 0.62
▸ TBK1 Q9UHD2 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22151634 0.93 STING1 (0.61) STING1TBK1
SCHEMBL19451755 0.92 STING1 (0.70) STING1TBK1
SCHEMBL28919520 0.92 STING1 (0.70) STING1TBK1
SCHEMBL23709447 0.92 STING1 (0.65) STING1TBK1
SCHEMBL21156976 0.88 STING1 (0.61) STING1TBK1
SCHEMBL23709337 0.88 STING1 (0.61) STING1TBK1
SCHEMBL23346489 0.86 STING1 (0.59) STING1TBK1
SCHEMBL24467597 0.86 STING1 (0.71) STING1TBK1
SCHEMBL23252150 0.86 STING1 (0.58) STING1TBK1
SCHEMBL23252124 0.86 STING1 (0.58) STING1TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238172-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS AND METHODS OF USING THE SAME GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238172-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS AND METHODS OF USING THE SAME AADAC, TAF15, HDAC10 STING1 748/4885TBK1 1160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback